Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04797039 · ClinicalTrials.gov registry record
MRI-Guided Cryoablation for Focal Native Prostate Cancer
A clinical trial of Primary Malignant Neoplasm of Prostate (Diagnosis), sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT04797039: Recruiting study of Primary Malignant Neoplasm of Prostate (Diagnosis), sponsored by Mayo Clinic.
NCT04797039 is a study of Primary Malignant Neoplasm of Prostate (Diagnosis) that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04797039, a study of Primary Malignant Neoplasm of Prostate (Diagnosis), is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to collect data about the MRI cryoablation procedure your doctor(s) would normally perform in order to treat the participants focal prostate cancer and to evaluate the participants condition after the participants treatment is performed. Participants have been asked to take part in this research because the participants have been diagnosed with prostate cancer and scheduled to have an ablation procedure.
Primary Outcome
Determine the technical success of the MR-guided cryoablation as measured by complete target lesion ablation.
Conditions Studied
Interventions
- PROCEDURE MR guided cryoablation
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2030-12 |
What NCT04797039 shows while recruiting
NCT04797039 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Primary Malignant Neoplasm of Prostate (Diagnosis) appearing as the primary indexed condition, and to 1 intervention - of which MR guided cryoablation is the first listed.
NCT04797039 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04797039 about?
NCT04797039 is a clinical study titled "MRI-Guided Cryoablation for Focal Native Prostate Cancer". The purpose of this research is to collect data about the MRI cryoablation procedure your doctor(s) would normally perform in order to treat the participants focal prostate cancer and to evaluate the participants condition after the participants treatment is performed. Participants have been asked ...
What is the current status of trial NCT04797039?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2020-12-01. Estimated completion is 2030-12.
What conditions does trial NCT04797039 study?
This clinical trial studies the following conditions: Primary Malignant Neoplasm of Prostate (Diagnosis).
What interventions are being tested in trial NCT04797039?
The interventions under investigation include: MR guided cryoablation (PROCEDURE).
Who is sponsoring clinical trial NCT04797039?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04797039 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI